| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Palivizumab 50 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Palivizumab 50 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 100 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 100 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Treosulfan 5 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Treosulfan 5 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Floxacillin (as floxacillin sodium) 500 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Floxacillin (as floxacillin sodium) 500 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| meropenem (som meropenemtrihydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| meropenem (som meropenemtrihydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Vinblastine sulfate 10 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Vinblastine sulfate 10 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely valproate sodium 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproate sodium 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Pentamidine isetionate 300 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Pentamidine isetionate 300 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Porfimer sodium 15 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Porfimer sodium 15 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Paclitaxel 100 mg powder for suspension for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Paclitaxel 100 mg powder for suspension for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Treosulfan 1 g powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Treosulfan 1 g powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
2 |
| Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Imiglucerase 400 unit powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Imiglucerase 400 unit powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Rifampicin 600 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Rifampicin 600 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Raltitrexed 2 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Raltitrexed 2 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Verteporfin 15 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Verteporfin 15 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| somatropin (rbe) 4 milligram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| somatropin (rbe) 4 milligram/injektionsflaska, pulver till injektionsvätska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
2 |
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension |
Has presentation strength denominator unit (attribute) |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Molgramostim 400 microgram powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
FHIR